Malaria prevention starts with knowing your destination and choosing the antimalarial that fits your specific itinerary. Travelers heading to sub-Saharan Africa, Southeast Asia, or parts of Latin America face genuine risk, and the medication you take matters. At our Travel Clinic, a travel health specialist matches you to the right protection strategy before you board.
By TravelBug Health Team, Travel Health Specialists
Understanding Malaria Risk by Destination
Malaria is a mosquito-borne disease caused by Plasmodium parasites and transmitted through bites from infected Anopheles mosquitoes. Not every international destination carries the same risk level. The CDC and WHO classify risk zones based on parasite species present, local transmission rates, and drug resistance patterns in that region.
Sub-Saharan Africa carries the world’s highest malaria burden, with Plasmodium falciparum, the most severe and drug-resistant species, dominating transmission. Southeast Asia, parts of Central and South America, and some Pacific Island countries also pose meaningful risk. Your specific itinerary shapes everything: a week in a major urban hotel differs substantially from a rural safari or jungle trek.
Before your clinic visit, gather your travel dates, the countries and regions you plan to visit, your accommodation types, and your planned outdoor activities. This detail directly shapes which antimalarial medications your travel health specialist will recommend.
The Antimalarial Medications Available to US Travelers
Several primary antimalarial drugs are available for malaria prevention in the United States. Each works through a different mechanism, suits different destinations, and carries its own dosing schedule and set of considerations.
Atovaquone-Proguanil (Malarone®)
Atovaquone-proguanil is among the most widely prescribed antimalarial medications for international travelers. You start it one to two days before entering a malaria risk area and continue for seven days after leaving. It is generally well-tolerated, with mild gastrointestinal discomfort as the most common side effect. It is highly effective against drug-resistant P. falciparum, making it a strong choice for sub-Saharan Africa and Southeast Asia.
Doxycycline
Doxycycline is an antibiotic that also functions as an effective antimalarial drug. Travelers start it one to two days before arrival in a risk area and continue for 28 days after departure. It is one of the more affordable medications available and accessible at most pharmacies. Photosensitivity is a notable side effect: you sunburn more easily, especially in tropical beach settings. Esophagitis (irritation of your esophagus) is also a known side effect and doxycycline can interact with other medications. Taking it with food and a full glass of water reduces stomach upset.
Mefloquine (Lariam®)
Mefloquine offers a once-weekly dosing schedule, which many travelers find convenient for longer trips. You start it two to three weeks before departure, continue weekly during travel, and finish four weeks after returning. Mefloquine is effective across most malaria regions, but the FDA has issued a black-box warning for neuropsychiatric side effects, including vivid dreams, anxiety, and in rare cases, more severe reactions. Your specialist reviews your full medical and mental health history before prescribing it.
Chloroquine
Chloroquine remains only effective in a few areas where P. falciparum resistance has not developed, primarily parts of Mexico, Central America, and some Caribbean countries. You take it weekly, starting one to two weeks before travel, and continue for four weeks after returning. In most of Africa, Southeast Asia, and South America, widespread drug resistance makes chloroquine a poor preventive choice for travelers.
Primaquine and Tafenoquine (Arakoda®)
Primaquine and tafenoquine are useful in areas where P. vivax malaria is common. Because they can cause serious side effects in people with a certain enzyme deficiency, a blood test is required before they are prescribed. They are not suitable for everyone, including pregnant travelers.
How Your Travel Health Specialist Selects the Right Antimalarial
Choosing an antimalarial is not a one-size-fits-all decision. Your travel health specialist weighs destination-specific drug resistance patterns and your personal medical history before writing any prescription.
Drug resistance patterns at your destination drive the first decision. Thomas Wellems and Christopher Plowe documented the molecular basis of chloroquine resistance in P. falciparum in the Journal of Infectious Diseases (2001), confirming that genetic mutations now make chloroquine ineffective across most of Africa and Southeast Asia. Ongoing CDC surveillance tracks these resistance patterns and informs prescribing guidelines each year.
Your medical history shapes the remaining choice. Patients with cardiac arrhythmias may avoid mefloquine due to effects on the cardiac QT interval. Doxycycline is contraindicated during pregnancy and in children under eight. Kidney and liver function can affect how the body processes atovaquone-proguanil. A history of depression or anxiety warrants an especially careful conversation before mefloquine is considered.
Trip length and logistics also enter the equation. A two-week safari pairs well with atovaquone-proguanil or doxycycline. A six-month backpacking trip through Southeast Asia may favor mefloquine’s once-weekly schedule to reduce daily pill burden and simplify travel logistics.
To pair your antimalarial plan with a complete vaccine schedule, review our Vaccinations page. For a walkthrough of what to expect at your pre-travel appointment, read What Happens at Your Scottsdale Travel Clinic Visit (Step by Step).
Malaria Prevention Beyond the Pill: Clothing, Repellents, and Bed Nets
Antimalarial drugs reduce your risk of developing disease if a mosquito bites you, but no medication is 100% protective. To prevent malaria, you must layer your prescription with physical barriers that limit the number of mosquito bites you receive in a risk area.
DEET-based repellents have long been the gold standard for travelers. The CDC recommends products containing 20 to 50 percent DEET for malaria-risk areas. Picaridin and IR3535 are effective alternatives for travelers who prefer a less oily formula. Apply repellent to all exposed skin (at least 30 min.) after sunscreen, and reapply as directed, especially after sweating or swimming.
Clothing choices matter, especially in areas with dense mosquito populations at dawn and dusk. Stay well covered with long-sleeved shirts, long pants and socks. Choose light colored clothing, such as khaki, which makes you less visible to mosquitoes and other insects. Consider adding an additional barrier of protection by pre-treating your clothes with permethrin, which effectively repels most insects, including mosquitoes. Permethrin-treated clothing retains its repellent effect through multiple wash cycles and provides consistent protection during outdoor activities when Anopheles mosquitoes are most active.
Sleeping under insecticide-treated bed nets in rural or budget accommodations adds another layer of protection against mosquitoes. A Cochrane review by Lengeler (2004) in The Cochrane Database of Systematic Reviews confirmed that insecticide-treated nets significantly reduce malaria cases and deaths in high-transmission areas.
For detailed guidance on repellent selection and application, read our guide to malaria prevention for travelers. If your itinerary includes the Caribbean or Latin America, also review Get Your Vaccines Now for December Travel to the Caribbean and Latin America to align your vaccine planning with your antimalarial prescription.
Recognizing Malaria Symptoms After You Return
Malaria prevention does not end when your flight lands back home. Antimalarial medications must be taken for the full prescribed course after leaving a risk area. Stopping early, particularly doxycycline’s 28-day post-travel course, creates a window of vulnerability when Plasmodium parasites can still establish an infection.
Malaria symptoms typically appear 7 to 30 days after a bite from an infected mosquito, though P. vivax and P. ovale can remain dormant in the liver and emerge months or up to a year later. Common symptoms include fever, chills, headache, muscle aches, nausea, and fatigue. Severe malaria caused by P. falciparum can progress rapidly to organ failure, cerebral complications, or death without prompt medical treatment.
If you develop fever within a year of returning from a malaria-risk region, tell your healthcare provider about your travel history immediately. Blood-based diagnostic tests identify the parasite species, which guides treatment selection and the specific drugs your physician will prescribe.
Students planning study-abroad semesters face the same exposure risks and prevention timelines. Read Travel Vaccines Every Arizona Study-Abroad Student Needs (2026 Checklist) for comprehensive pre-travel health preparation, including antimalarial planning.
Frequently Asked Questions
Do I need antimalarial medication for every international trip?
No. Antimalarial drugs are indicated only for travel to areas with active malaria transmission. Countries in Western Europe, Australia, Japan, and much of the Caribbean do not require prophylaxis. Your travel health specialist reviews your itinerary, including specific countries, regions, and planned activities, to determine whether antimalarial medication is medically appropriate for your trip.
When should I start taking antimalarial medication before travel?
Timing depends on the drug. Atovaquone-proguanil and doxycycline both start one to two days before you enter a malaria-risk area. Mefloquine requires a two-to-three-week lead before exposure. Starting a medication on schedule ensures therapeutic drug levels are present in your system when you arrive in a risk area and need protection.
Can I get antimalarial medication without visiting a travel clinic?
Antimalarial drugs require a prescription in the United States. A travel clinic visit provides destination-specific drug selection, a dosing schedule tailored to your trip length, and guidance on managing side effects. A general practitioner may not have current regional resistance data, which can affect drug selection and leave you under-protected at your specific destination.
Are antimalarial medications safe for children and pregnant travelers?
Atovaquone-proguanil is approved for children weighing at least five kilograms, using a lower-dose pediatric formulation. Doxycycline is contraindicated in children under eight and in pregnant women. Mefloquine may be considered during pregnancy when benefits outweigh risks. Chloroquine is generally the safest option in pregnancy; but only for destinations where it remains effective. A travel health specialist should guide all pediatric and pregnancy-specific antimalarial decisions.
What should I do if I miss a dose of my antimalarial?
For daily medications like atovaquone-proguanil or doxycycline, take the missed dose as soon as you remember, unless your next dose is within a few hours. For weekly medications like mefloquine or chloroquine, take the missed dose within a week of your scheduled day. Never double up doses. Reach out to our office with any questions about your specific prescription and schedule.
Build Your Malaria Prevention Plan at Our Scottsdale Clinic
Choosing the right antimalarial for your trip is a medical decision shaped by your destination, your health history, and how long you will spend in risk areas. Contact Us to schedule your pre-travel consultation at our Scottsdale clinic, where our travel health specialists will assess your itinerary and build a complete, personalized malaria prevention strategy.
